12:00 AM
 | 
Jan 12, 2009
 |  BioCentury  |  Finance

Top biotech products

Top biotech products

At least 28 drugs developed and marketed by biotech companies are expected to have more than $500 million in annual sales in 2008. Product sales as reported by listed companies below. Cancer drug Erbitux cetuximab dropped off the list after ImClone was acquired by EliLilly (NYSE:LLY). (A) 2008 sales projected from 1H08 sales figure; (B) Global in-market sales figures; $M

Company Product 2007 sales 2008 9-mo sales 2008 run rate Projected chg
Amgen (NASDAQ:AMGN)/Wyeth (NYSE:WYE)/ Takeda (Tokyo:4502) Enbrel etanercept

Read the full 528 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >